Home2020-06-11T19:15:37+00:00

Reject Coverage Limits on Kidney Transplant Care

Medicare’s 3-year coverage limit on immunosuppressive medications costs transplant patients their lives and Medicare millions. Help us honor the gift of life by protecting kidney transplants.

CONTACT CONGRESS

REAL PATIENTS. REAL STORIES.

Medicare’s coverage limit on anti-rejection drugs impacts thousands of kidney transplant patients across the country. These are their stories.

Monica Fox

“All of a sudden, the rug is pulled out from under you.”

Monica received her kidney transplant on Thanksgiving Eve 2016 but lives every day knowing as of next winter, her coverage of immunosuppressive medications isn’t a guarantee. Listen to Monica’s story.

Read More

Alexandra Harrison Flaxman

“Knowing that you’ll have your medications is just one less thing to worry about.”

Alexandra is living proof that the availability of private insurance alone cannot guarantee coverage for immunosuppressive medications. Knowing that their lifesaving anti-rejection medications are covered would give kidney transplant patients like Alexandra, “one less thing to worry about.”

Read More

Natalie and Mark Mirage

“I’m 16 and I have a lot of life to live.”

The relief of Natalie receiving her transplant in 2014 is overshadowed by the lack of guaranteed coverage for the immunosuppressive treatments she’ll need for the rest of her life. Watch Natalie and Mark discuss their fears and hopes for the future.

Read More
EXPLORE OUR OTHER PATIENT STORIES

Contact your member of Congress now!

The impact of the coronavirus pandemic has made one thing clear: it’s time to guarantee Medicare coverage of immunosuppressive medications for kidney transplant patients! Millions of Americans have lost their jobs, which for many, also results in the loss of employer provided health insurance. Congress – don’t let COVID-19 stand in the way of kidney recipients and their anti-rejection medications. Include the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act in the next COVID-19 relief legislation.

H.R. 5534 and S. 3353 would…

  1. Protect kidney transplant patients and decrease their risk of organ rejection
  2. Result in significant savings to Medicare, according to the Congressional Budget Office
  3. #HonorTheGift of kidney donation
  4. Use smart policy to save lives and provide relief to American families suffering from the financial impact of COVID-19

POLICY OVERVIEW

The Immunosuppressive Drug Coverage for Kidney Transplant Patients Act is a straightforward solution to an unnecessary problem – this legislation honors the gift of transplantation, protects patients, and saves Medicare money by extending coverage of life-saving immunosuppressive medications to the lifespan of the transplanted organ.

0
Kidney transplant recipients at risk of losing Medicare coverage each year
$0
Average annual cost Medicare pays for kidney transplant recipients’ immunosuppressive medications
0%
of U.S. kidney-transplantation programs reported deaths and organ transplant losses due to patients’ inability to pay for their anti-rejection medications
0M
The estimated savings to Medicare over 10 years
MORE ON POLICY

SIGN UP FOR EMAIL UPDATES

Stay up-to-date on our efforts to honor the gift and extend Medicare coverage of immunosuppressive medication

WORKING TOGETHER TO HONOR THE GIFT